Indication
Plasmodium falciparum malaria
Plasmodium falciparum malaria is a life-threatening protozoan infection primarily transmitted to humans by the bite of an infected female *Anopheles* mosquito. Read more about Plasmodium falciparum malaria
69 drugs 52 manufacturers
Drugs that treat it
Common Plasmodium falciparum malaria therapies.
HYDROXYCHLOROQUINE SULFATE
HYDROXYCHLOROQUINE SULFATE
HYDROXYCHLOROQUINE SULFATE
QUININE SULFATE
HYDROXYCHLOROQUINE (hydroxychloroquine sulfate)
QUININE SULFATE
HYDROXYCHLOROQUINE SULFATE
MALARONE (atovaquone/proguanil HCl)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPlasmodium falciparum malaria is a life-threatening protozoan infection primarily transmitted to humans by the bite of an infected female *Anopheles* mosquito.
The pathogen targets the hepatic and hematologic systems, where asexual replication within erythrocytes leads to widespread red blood cell destruction and systemic inflammation.
Pathophysiologically, mature infected erythrocytes express surface adhesion ligands that promote cytoadherence and vascular sequestration within microcapillary beds, predisposing patients to profound microvascular obstruction, severe anemia, metabolic acidosis, acute respiratory distress, and cerebral malaria.
While young children, pregnant individuals, and non-immune travelers bear the greatest risk of rapidly progressive, fatal disease, the infection remains a critical global threat across all exposed populations.
- cdc.gov
Plasmodium falciparum malaria is a life-threatening protozoan infection primarily transmitted to humans by the bite of an infected female *Anopheles* mosquito The pathogen targets the hepatic and hematologic systems, where asexual replication within erythrocytes leads to widespread red blood cell destruction and systemic inflammation
- who.int
Plasmodium falciparum malaria is a life-threatening protozoan infection primarily transmitted to humans by the bite of an infected female *Anopheles* mosquito While young children, pregnant individuals, and non-immune travelers bear the greatest risk of rapidly progressive, fatal disease, the infection remains a critical global threat across all exposed populations
- cdc.gov
The pathogen targets the hepatic and hematologic systems, where asexual replication within erythrocytes leads to widespread red blood cell destruction and systemic inflammation Pathophysiologically, mature infected erythrocytes express surface adhesion ligands that promote cytoadherence and vascular sequestration within microcapillary beds, predisposing patients to profound microvascular obstruction, severe anemia, metabolic acidosis, acute respiratory distress, and cerebral malaria
Personalize your experience
Follow Plasmodium falciparum malaria and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.